606 related articles for article (PubMed ID: 7505803)
1. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
Beasley D; McGuiggin M
J Exp Med; 1994 Jan; 179(1):71-80. PubMed ID: 7505803
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.
Beasley D; Schwartz JH; Brenner BM
J Clin Invest; 1991 Feb; 87(2):602-8. PubMed ID: 1671393
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.
Marsden PA; Ballermann BJ
J Exp Med; 1990 Dec; 172(6):1843-52. PubMed ID: 1979590
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 beta and tumor necrosis factor-alpha synergistically induce NO synthase in rat vascular smooth muscle cells.
Beasley D; Eldridge M
Am J Physiol; 1994 Apr; 266(4 Pt 2):R1197-203. PubMed ID: 7514363
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 induces prostacyclin-dependent increases in cyclic AMP production and does not affect cyclic GMP production in human vascular smooth muscle cells.
Beasley D; McGuiggin ME
Cytokine; 1995 Jul; 7(5):417-26. PubMed ID: 7578979
[TBL] [Abstract][Full Text] [Related]
6. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
[TBL] [Abstract][Full Text] [Related]
7. cGMP upregulates nitric oxide synthase expression in vascular smooth muscle cells.
Inoue T; Fukuo K; Nakahashi T; Hata S; Morimoto S; Ogihara T
Hypertension; 1995 Apr; 25(4 Pt 2):711-4. PubMed ID: 7536712
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle.
Beasley D
Am J Physiol; 1990 Jul; 259(1 Pt 2):R38-44. PubMed ID: 1695820
[TBL] [Abstract][Full Text] [Related]
9. Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats.
Singh A; Sventek P; Larivière R; Thibault G; Schiffrin EL
Am J Hypertens; 1996 Sep; 9(9):867-77. PubMed ID: 8879343
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes. Involvement of the nitric oxide synthase pathway.
Kolb JP; Paul-Eugene N; Damais C; Yamaoka K; Drapier JC; Dugas B
J Biol Chem; 1994 Apr; 269(13):9811-6. PubMed ID: 7511593
[TBL] [Abstract][Full Text] [Related]
11. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
Fleming I; Julou-Schaeffer G; Gray GA; Parratt JR; Stoclet JC
Br J Pharmacol; 1991 May; 103(1):1047-52. PubMed ID: 1678981
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide enhances PGI(2)production by human pulmonary artery smooth muscle cells.
Wen F; Watanabe K; Yoshida M
Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):369-78. PubMed ID: 10913230
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide synthase induction, cGMP elevation, and biopterin synthesis in vascular smooth muscle cells stimulated with interleukin-1beta in hypoxia.
Nagao K; Takenaka S; Yamaji R; Inui H; Nakano Y
J Biochem; 2003 Apr; 133(4):501-5. PubMed ID: 12761298
[TBL] [Abstract][Full Text] [Related]
14. Lipoteichoic acid: a new inducer of nitric oxide synthase.
Lonchampt MO; Auguet M; Delaflotte S; Goulin-Schulz J; Chabrier PE; Braquet P
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S145-7. PubMed ID: 1282952
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation.
Nunokawa Y; Tanaka S
Biochem Biophys Res Commun; 1992 Oct; 188(1):409-15. PubMed ID: 1384487
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of cGMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cells.
Browner NC; Sellak H; Lincoln TM
Am J Physiol Cell Physiol; 2004 Jul; 287(1):C88-96. PubMed ID: 14985234
[TBL] [Abstract][Full Text] [Related]
18. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells.
Busse R; Mülsch A
FEBS Lett; 1990 Nov; 275(1-2):87-90. PubMed ID: 1702067
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats.
Wu CC; Chen SJ; Yen MH
Am J Physiol; 1998 Oct; 275(4):H1148-57. PubMed ID: 9746461
[TBL] [Abstract][Full Text] [Related]
20. Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells.
Kusano E; Tian S; Umino T; Tetsuka T; Ando Y; Asano Y
J Hypertens; 1997 Jun; 15(6):627-32. PubMed ID: 9218182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
